article_snippet.sent: standard treatment are testing the drug Sulforadex in the most common type of breast cancer, affecting 70 per cent of patients.
article_snippet.sent: The combination therapy, tested in mice and samples of tissue from secondary breast cancer patients, combines Sulforadex with standard hormonal treatments.
article_snippet.sent: Dr Rob Clarke and Rob Clarke research team have demonstrated the efficacy of Sulforadex.
article_snippet.sent: Dr Rob Clarke and his research team now intend to extend this collaboration and advance Sulforadex into a clinical trial with breast cancer patients.
article_snippet.sent: ‘Combining tamoxifen with Sulforadex resulted in fewer breast cancer stem cells surviving treatment compared to tamoxifen alone, lowering the likelihood of breast cancer returning or spreading to other parts of the body.
article_snippet.sent: We hope that planned clinical trials will follow quickly to tell We whether using tamoxifen with Sulforadex is safe and can deliver similar results in humans.
highlights_snippet.sent: Treatment combines Sulforadex with standard hormonal treatments .